Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Khiron Life Sciences Corp. (V:KHRN)

Business Focus: Alternative Medicine

Get the company report for the most recent outlook updated daily

Insider Chart - Past 6 Months

Insider Filings

Latest 10 SEDI filings for KHRN within the last 6 months
Loading...
See all filings within the past 6 months

Company News

Nov 18, 2022 06:50 ET
Khiron to Host Third Quarter 2022 Conference Call on November 30, 2022
TORONTO, Nov. 18, 2022 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMXC), the global leader in medical cannabis throughout Latin America and Europe, today announces that it will host a Conference Call on November 30, 2022 at 11:00 a.m. eastern time to discuss its results for the third quarter ended September 30, 2022. The Company will press release its financial results prior to the Conference Call. These filings will be available for review on the Company's SEDAR profile at www.sedar.com
Read full article
Nov 18, 2022 06:50 ET
Khiron to Host Third Quarter 2022 Conference Call on November 30, 2022
TORONTO, Nov. 18, 2022 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMXC), the global leader in medical cannabis throughout Latin America and Europe, today announces that it will host a Conference Call on November 30, 2022 at 11:00 a.m. eastern time to discuss its results for the third quarter ended September 30, 2022. The Company will press release its financial results prior to the Conference Call. These filings will be available for review on the Company's SEDAR profile at www.sedar.com
Read full article
See more news stories

Valuation Ratios

Industry
Sector
Beta
2.01
--
--
Price to Sales - TTM
1.21
3.10
3.57
Price to Book - most recent quarter
0.63
1.06
1.69
Price to Cash Flow per share - TTM
--
7.46
8.89
Price to Free Cash Flow per share - TTM
--
8.32
12.77
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Nov 15, 2022146,8642,084
Oct 31, 2022144,780-74,903
Oct 15, 2022219,683135,321
See Short Report

Business Summary

Sector:  Healthcare Industry:  Pharmaceuticals

Khiron Life Sciences Corp. (Khiron) is a vertically integrated international medical cannabis company with core operations in Latin America and Europe. The Company's product lines include medical cannabis products, health services and wellbeing products. The medical cannabis product sells branded medical cannabis products. The health service operates its own network of medium complexity health centers (operating under the ILANS and Zerenia brands) and Zerenia satellite clinics offering a range of health, medical and surgical services in alignment with insurance company partners. Its wellbeing product is focused on delivering the benefits of cannabidiol (CBD) a range of various branded consumer packaged goods, such as its Kuida cosmetics line. The Company provides patient-oriented approach, physician education programs, scientific expertise, product innovation, and agricultural infrastructure. The Company sells its products in Colombia, Peru, Germany, United Kingdom and Brazil.

See business summary

 

Twitter

Search (past week) for $KHRN.CA KHRN.V

  • No tweets found